“…Thus, in p53 +/+ Eμ-Myc male pre-tumoral splenocytes, an increased Ackr4 expression might delay lymphomagenesis in part by attenuating Myc signalling. Indeed, the observed lower expression of Mt2, known to be regulated by Myc (Qin et al, 2021 ), appears consistent with this hypothesis. Importantly, Ackr4 was previously found to inhibit the growth and metastasis of breast, cervical, colorectal, hepatocellular and nasopharyngeal cancer cells (Feng et al, 2009 ;Hou et al, 2013 ;Ju et al, 2019 ;Shi et al, 2015 ;Zhu et al, 2014 ), although no report mentioned any sex-specific bias for cancers occurring in both sexes.…”